Italy Self-Monitoring Blood Glucose Devices Market Size (2024 - 2029)

The Italy Self-Monitoring Blood Glucose Devices Market is projected to experience growth over the forecast period, driven by advancements in diabetes care technologies and the increasing importance of routine diabetes management. The COVID-19 pandemic underscored the need for innovative solutions, such as virtual consultations and digital health apps, which have become integral in supporting diabetes self-management and reducing health complications. These developments are expected to enhance the market's potential, as they offer additional support to patients with poorly controlled diabetes, thereby improving health outcomes and expanding market opportunities.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Monitoring Devices Research Single time Monitoring Devices Research Italy Self-Monitoring Blood Glucose Devices Market Market Size

Market Size of Italy Self-Monitoring Blood Glucose Devices Industry

Italy Self-Monitoring Blood Glucose Devices Market Summary
Study Period 2018 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 1.20 Billion
Market Size (2029) USD 1.30 Billion
CAGR (2024 - 2029) 5.92 %

Major Players

Italy Self-Monitoring Blood Glucose Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Italy Self-Monitoring Blood Glucose Devices Market Analysis

The Italy Self-Monitoring Blood Glucose Devices Market size is estimated at USD 1.20 billion in 2024, and is expected to reach USD 1.30 billion by 2029, growing at a CAGR of 5.92% during the forecast period (2024-2029).

The first year since its inception, the COVID-19 pandemic was responsible for premature deaths, particularly among older individuals. Italy was the first country in Europe affected by COVID-19. Italy was among the countries with the highest mortality rates. Most people who died of COVID-19 were affected by the co-occurrence of two or more chronic conditions in the same individual. Several studies confirmed that chronic diseases like diabetes were associated with adverse outcomes in COVID-19 patients. The pandemic highlighted opportunities for continuing and expanding innovations in the delivery of diabetes care through virtual consultations between healthcare providers and people with diabetes and the use of diabetes technology. Routine diabetes management was essential to mitigate the risk of adverse health outcomes and severe COVID-19 in diabetes patients; however, the pandemic contributed to disruptions in diabetes management.

Blood glucose monitoring increases patients' awareness of glucose values, which supports healthy lifestyle choices. Blood glucose monitoring values help provide feedback and guidance on how to make health behavior changes when needed. Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.

Innovative technologies, such as digital health apps that display and summarize individual blood glucose measurements and incorporate additional relevant data such as insulin doses, meals and snacks, and physical activity, can further support self-management while decreasing disease burden and benefiting overall diabetes care. Integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes with the additional support needed to improve critical outcomes, thereby enhancing market prospects in the years to come.

Italy Self-Monitoring Blood Glucose Devices Industry Segmentation

Self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood sugar level themselves using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The Italy self-monitoring blood glucose devices market is segmented by components. The report offers the value (in USD) and volume (in units) for the above segments.

Component
Glucometer Devices
Test Strips
Lancets
Need A Different Region Or Segment?
Customize Now

Italy Self-Monitoring Blood Glucose Devices Market Size Summary

The Italian self-monitoring blood glucose devices market is poised for growth, driven by the increasing prevalence of diabetes and advancements in diabetes care technology. The market is characterized by a commitment to self-monitoring among diabetic patients, which is crucial for managing blood sugar levels and preventing complications. Innovative technologies, such as digital health apps and integrated monitoring systems, are enhancing self-management capabilities and reducing the disease burden. The Italian healthcare system, with its decentralized structure and patient-centered National Diabetes Plan, plays a significant role in facilitating access to diabetes care and technologies. Government policies and the Italian National Healthcare Service ensure universal coverage, providing citizens with the necessary medical services and devices without out-of-pocket expenses.

The market landscape is competitive, with major players like Abbott, LifeScan, Roche, and Ascensia holding significant shares. The test strip segment dominates the market due to its frequent use and continuous investment nature, contrasting with the one-time purchase of glucose meters. Regulatory frameworks and reimbursement policies further support market growth by ensuring comprehensive clinical care and financial accessibility for diabetic patients. Recent innovations, such as Bluetooth-connected meters and mobile apps, underscore the ongoing advancements in diabetes management. The market's expansion is expected to continue, supported by these technological developments and the increasing demand for effective diabetes care solutions.

Explore More

Italy Self-Monitoring Blood Glucose Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Component

      1. 2.1.1 Glucometer Devices

      2. 2.1.2 Test Strips

      3. 2.1.3 Lancets

Italy Self-Monitoring Blood Glucose Devices Market Size FAQs

The Italy Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 1.20 billion in 2024 and grow at a CAGR of 5.92% to reach USD 1.30 billion by 2029.

In 2024, the Italy Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 1.20 billion.

Italy Self-Monitoring Blood Glucose Devices Market Report Snapshots

Italy Self-Monitoring Blood Glucose Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2024 - 2029)